GlobeNewswire

Christian Gentner, Ph.D., Joins Zageno as Vice President European Sales

Del

Highly consultative method of sales ensures each customer’s unique needs are heard, understood, and served to create a tailored solution that simplifies and streamlines administrative laboratory purchasing tasks across the enterprise and lets them focus on what really matters: their scientific and business milestones

CAMBRIDGE, Mass. USA and BERLIN, Germany, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Zageno Inc. , the largest and fastest-growing online marketplace for the research scientist, has just named Christian Gentner, Ph.D., vice president, European sales. A seasoned sales executive, with nearly two decades of sales leadership experience in pharmaceutical and medical devices at companies such as Sanofi-Aventis, Essex Pharma, Bristol-Myers Squibb, Aspen Germany GmbH, and most recently, Urgo Medical — Gentner joined Zageno to evolve the company’s sales and commercial processes to support an expanded, multi-channel approach. This highly consultative method of sales ensures each customer’s unique needs are heard, understood, and served.

“We’ve had tremendous momentum, and our young sales team has done extraordinarily well, enabling us to far exceed our growth goals to date. We’re very excited to have Christian join us to take us to the next level of commercialization,” said Zageno Chief Executive Officer David Pumberger, Ph.D. “He has the skills, track record, and experience to transition our sales approach so that we become a more consultative, specific solutions provider for our various types of customers — from academic and government research institutions, biotechs startups and pharmaceuticals companies large and small —to CRO labs. His ability to lead, train, and mentor a team, and work in a cross-functional way was a key factor in our hiring decision.”

Zageno has three primary focus groups within in each customer site: the research scientists, the lab manager, and purchasing administrator. Its online marketplace and enterprise offering serves all three functions — simplifying and streamlining product selection through approvals to order receipt.

AtBMS, Gentner was a key member of a multi-function pre-launch team that provided the critical voice-of-the-customer perspective, allowing for the team to have customer-based, 360-degree insight for the HCV pipeline of products. As a result, he outperformed the sales goal post-launch. 

Zageno Chief Revenue Officer Florian Wegener, M.D., M.B.A., Ph.D., commented, “At Zageno, we work hand-in-hand with our customers in the U.S., Germany, and the U.K. to provide a tailored solution that simplifies and streamlines administrative laboratory purchasing tasks across the enterprise to let them focus resources on what really matters: their scientific and business milestones. With Christian’s extensive connections, knowledge about, and stellar reputation within our target customer groups — we will be very well positioned to deliver excellent customer service and meet their specific needs.”  

Genter’s approach is metrics-based, with a time horizon greater than the typical one-year sales outlook. His sales plans are linked strongly to both leadership’s key performance indicators (KPI) and the company’s strategic plan. This longer-range vision allows him to analyze the marketplace ecosystem and take a proactive approach in identifying opportunities and mitigating risks. Hegives his team members ownership of their territories and accounts, providing regular mentoring and check-in sessions to help them go beyond the science to become even more effective listeners and communicators to ensure that customers’ known and latent needs are met successfully. It’s how he’s built a strong track record of consistently delighting customers and exceeding sales goals.

About Zageno Inc. (www.zageno.com;  twitter: @ZAGENOteam)
Founded in 2015, Zageno is eliminating bottlenecks to breakthrough science and research through curated connections linking scientists and their institutions’ procurement offices with leading life-science vendors. World-renowned academic and government research facilities, global pharmaceutical companies, and biotechs large and small are already users of our unique online biotech marketplace, currently comprising about five million products. What do we do? 1) We make purchasing transactions more efficient for both buyers and sellers. 2) We help scientists choose the optimal laboratory kits and materials for each unique experiment setup. 3) We provide a valuable, expanded sales channel for our vendor partners. The growing Zageno team of 60 in Cambridge, USA, and Berlin, Germany, includes accessible experts in science, e-commerce, systems integration, and customer support. Our people work directly with customers to enable smarter, faster processes — allowing more time and resources for value-added science and better research results.

Attachments

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Bio-Fence announces a breakthrough in Food Safety18.1.2019 08:11Pressemelding

The company have successfully completed a field trial of its new anti-microbial coating technology. The trials demonstrated a significant reduction in bacterial contamination during sensitive food production processes ASHDOD, Israel, Jan. 18, 2019 (GLOBE NEWSWIRE) -- Bio-Fence innovating coating technology announced today the successful completion of an intensive field trial on its innovative anti-microbial technology Pentagon. The trial was held in "Milouoff" (http://www.milouoff.co.il), one of the largest Ready to Eat poultry production sites in Israel and demonstrated superior results for Bio-Fence technology compared to alternatives. According to Mrs. Shiran Davidi, QA manager at Milouoff: “Bio-Fence technology seems to have clear benefits over existing antimicrobial solution. It is safe, highly potent and rechargeable.” The trial involved monitoring the performance of an epoxy floor coated with Bio-Fence anti-microbial technology compared to either commercial Silver Ion coating an

ERYTECH Presents TRYbeCA-1 Trial-in-Progress Poster at the 2019 ASCO GI Annual Meeting18.1.2019 07:00Pressemelding

LYON, France and CAMBRIDGE, Mass., Jan. 18, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, announced that a poster entitled “TRYbeCA-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)” will be presented today at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in San Francisco. The poster (Abstract # TPS471) will be available at www.erytech.com after presentation at the conference. In September 2018, the TRYbeCA-1 trial was initiated. The Trial-in-Progress poster will provide an update on the study progress with investigators sites that have been initiated in multiple countries and actively recruiting patients. The trial is planned to enroll approximately 500 patients with

Fossil Group Enters Agreement To Sell Select Smartwatch Technology To Google17.1.2019 18:30Pressemelding

Transaction Unlocks Growth Opportunities for Fossil Group’s Wearables Business RICHARDSON, Texas, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Today, Fossil Group (NASDAQ:FOSL) announced its plan to sell to Google for $40 million intellectual property (IP) related to a smartwatch technology currently under development by Fossil Group. As part of the transaction, a portion of Fossil Group’s research and development (R&D) team currently supporting the transferring IP will join Google. Fossil Group retains more than 200 R&D team members to focus on innovation and product development. The transaction showcases Fossil Group and Google’s shared investment in the wearables industry. In recent years, smartwatches have become Fossil Group’s fastest growing category. The company successfully developed and launched smartwatches across 14 of its owned and licensed brands. “Fossil Group has experienced significant success in its wearables business by focusing on product design and development informed by our

Calgon Carbon Corporation Announces Global Price Increase17.1.2019 17:16Pressemelding

Pittsburgh, PA, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Calgon Carbon Corporation today announced a global price increase, effective February 1, 2019, where contracts permit, on all activated carbon products and related equipment due to a continued escalation in raw material costs and transportation expenses. The increase is expected to range between 10-15%, depending on the specific product, raw material type, services provided, and global market dynamics. The primary raw materials used for producing activated carbon are coal, coconut shell, and wood, each of which has gone up in price. Additionally, costs associated with both operating manufacturing facilities and transporting materials have also escalated. “Calgon Carbon’s raw material costs have increased significantly. Despite every effort to offset these increases through continuous improvements, the recent rise in raw material costs has exceeded our efforts,” said Jim Coccagno, Chief Commercial Officer for Calgon Carbon Corporation. “

Taconic Biosciences’ Animals Complete Most Recent Mission to the International Space Station17.1.2019 15:29Pressemelding

RENSSELAER, N.Y., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the completion of a recent mission to the International Space Station. This project represents a collaboration between the International Space Station (ISS) National Lab, National Aeronautics and Space Administration (NASA), Bioserve Space Technologies with support from the Leidos Corporation, and Taconic. Taconic has participated in several spaceflight missions with NASA since 1985. Most recently, as part of the science and research investigation payloads supported by the SpaceX Commercial Resupply Services missions, Taconic prepared mice to live aboard the International Space Station for extended periods. Previous spaceflight studies demonstrated that mice undergo rapid loss of muscle and bone mass, resembling accelerated aging. Therefore, mice exposed to microgravity via spaceflight are a valuable model to understand and devel

MPP Global Bridges the Innovation Gap by Centralising Physical and Digital Subscriber Management and Billing in a Single Cloud Platform17.1.2019 12:29Pressemelding

WARRINGTON, UK, Jan. 17, 2019 (GLOBE NEWSWIRE) -- MPP Global, the technology company that delivers eSuite, the world’s smartest subscriber management & billing platform, announces the launch of pivotal new functionality which enables media organisations to seamlessly create and manage the sale of physical subscriptions. This positions eSuite as the complete physical and digital subscription management solution. The development of this industry-first functionality was borne out of the common challenge for publishers when managing multiple systems for deploying bundled print and digital subscriptions. This is inflexible for publishers and limits choice for their customers, restricting the ability to seamlessly create and offer digital and print subscription bundles. Despite increased consumer uptake of digital subscriptions, print still accounts for almost 90% of circulation revenues globally. To drive reader revenues successfully, publishers require functionality to execute complementar